Logo

GSK

Precision Cancer Consortium Launches With Bayer, GSK, Roche, Novartis as Founding Members

The organization of pharmaceutical and biotechnology firms aims to increase access to genomic testing for cancer patients.

23andMe Gets $50M Payment as GSK Extends Companies' Drug Discovery Alliance

The companies are using 23andMe's extensive genotype-phenotype database and other resources to identify targets for personalized therapeutics, continuing an alliance begun in 2018.

UK Biobank WGS Consortium Describes 150K Genome Dataset at ASHG, Sets Sights on 500K
Premium

Researchers described the variant, disease, drug target, and drug safety insights being gained analyzing more than 150,000 UK Biobank whole-genome sequences.

COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020

The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.

Dec 7, 2020

UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects

Nov 11, 2020

Adaptive Biotechnologies, GlaxoSmithKline Collaborate on MRD Testing

Oct 21, 2020

UK Biobank Exomes Reveal Loss-of-Function Variants, Potential Disease Ties

Oct 7, 2020

Nvidia Expands Genomics Activities With Supercomputer, New Partnerships
Premium

Jul 28, 2020

Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease
Premium

May 20, 2020

Mammoth Biosciences, GSK Developing CRISPR-Based SARS-CoV-2 Diagnostic for Home Testing
Premium

Apr 30, 2020

GSK Gets Broad Zejula Indication in Ovarian Cancer; FDA Deems Myriad Genetics' Test Complementary

Apr 8, 2020

Novacyt, AstraZeneca, GSK, University of Cambridge Partner to Increase SARS-CoV-2 Testing in UK

Jan 23, 2020

Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

Oct 29, 2019

FDA Approval of Myriad Genetics CDx Adds HRD to Growing List of Ovarian Cancer Predictive Markers
Premium

Oct 28, 2019

Study Finds Residual Protein Expression Common After CRISPR Knockout

Oct 23, 2019

FDA Approves GSK's Zejula Alongside Myriad Genetics CDx for Advanced Ovarian Cancer

Sep 11, 2019

UK Biobank Whole-Genome Sequencing Project Obtains £200M from Pharma, Government, Philanthropy

Jun 24, 2019

SpeeDx, GSK Sign Test Supply, Development Deal

Jun 13, 2019

GlaxoSmithKline, UC's Doudna Establish $67M Genomics, CRISPR Research Lab

Apr 9, 2019

Myriad Submits MyChoice HRD as Companion Diagnostic for GSK's Zejula

Mar 25, 2019

UK Biobank to Make Whole-Genome Sequencing Data on 500K-Sample Repository Publicly Available
Premium

Jan 25, 2019

In Brief This Week: Illumina, Novacyt, Twist Bioscience, iGene Laboratory, More

Jul 26, 2018

GSK, 23andMe Gamble on Personalized Drug Discovery With Exclusive Deal
Premium

Jul 25, 2018

23andMe, GSK Ink Exclusive Drug Target Discovery Pact

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.